Edyta Stodółkiewicz-Nowarska

Dr. Edyta Stodółkiewicz-Nowarska


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SSSebastian M. Stec
Sebastian M. Stec
AWAntoni Wileczek
Antoni Wileczek
ARAgnieszka Reichert
Agnieszka Reichert
JŚJanusz Śledź
Janusz Śledź
JKJarosław Kosior
Jarosław Kosior
ESEdyta Stodółkiewicz-Nowarska
Edyta Stodółkiewicz-Nowarska
Background: Safe discontinuation of pacemaker therapy for vagally mediated bradycardia is a dilemma. The aim of the study was to present the outcomes of a proposed diagnostic and therapeutic process aimed at discontinuing or not restoring pacemaker therapy (PPM) in patients with vagally mediated bradycardia. Methods: The study group consisted of two subgroups of patients with suspected vagally mediated bradycardia who were considered to have PPM discontinued or not to restore their PPM if cardioneuroablation (CNA) would successfully treat their bradycardia. A group of 3 patients had just their pacemaker explanted but reimplantation was suggested, and 17 patients had preexisting pacemakers implanted. An invasive electrophysiology study was performed. If EPS was negative, extracardiac vagal nerve stimulation (ECVS) was performed. Then, patients with positive ECVS received CNA. Patients with an implanted pacemaker had it programmed to pace at the lowest possible rate. After the observational period and control EPS including ECVS, redo-CNA was performed if pauses were induced. The decision to explant the pacemaker was obtained based on shared decision making (SDM). RESULTS: After initial clinical and electrophysiological evaluation, 17 patients were deemed eligible for CNA (which was then performed). During the observational period after the initial CNA, all 17 patients were clinically asymptomatic. The subsequent invasive evaluation with ECVS resulted in pause induction in seven (41%) patients, and these patients underwent redo-CNA. Then, SDM resulted in the discontinuation of pacemaker therapy or a decision to not perform pacemaker reimplantation in all the patients after CAN. The pacemaker was explanted in 12 patients post-CNA, while in 2 patients explantation was postponed. During a median follow-up of 18 (IQR: 8–22) months, recurrent syncope did not occur in the CNA recipients. Conclusions: Pacemaker therapy in patients with vagally mediated bradycardia could be discontinued safely after CNA.

13 December 2022 in Cardiology Journal
Verified
Journal Article
Open access
PDF file
SSSebastian M. Stec
Sebastian M. Stec
BJBeata Jankowska-Polańska
Beata Jankowska-Polańska
DJDariusz Jagielski
Dariusz Jagielski
AWAntoni Wileczek
Antoni Wileczek
KJKrystian Josiak
Krystian Josiak
ESEdyta Stodółkiewicz-Nowarska
Edyta Stodółkiewicz-Nowarska
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

29 June 2013 in Polish Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
ESEdyta Stodółkiewicz-Nowarska
Edyta Stodółkiewicz-Nowarska
AZAndrzej Ząbek
Andrzej Ząbek
ACAnton Chrustowicz
Anton Chrustowicz
KBKrzysztof Boczar
Krzysztof Boczar
BMBarbara Małecka
Barbara Małecka
KŻKrzysztof Żmudka
Krzysztof Żmudka
DOI: 10.20452/pamw.1788, Published online: June 29, 2013, Authors: Edyta Stodółkiewicz, Andrzej Ząbek, Anton Chrustowicz, Krzysztof Boczar, Barbara Małecka, Krzysztof Żmudka